Cell line · CVCL_0080
A-673
Cancer cell line, Homo sapiens. Ewing sarcoma. Cellosaurus records it as misclassified. 84 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. A-673. Cell lines, record CVCL_0080. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0080
On this page
Cell line
As Cellosaurus gives it.
- Name
- A-673
- Accession
- CVCL_0080
- RRID
- RRID:CVCL_0080
- Synonyms
- A673, RMS 1598, RMS1598
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 15Y
- Category
- Cancer cell line
- Diseases
- Ewing sarcoma (NCIt C4817); Ewing sarcoma (ORDO Orphanet_319)
- Derived from
- Muscle (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Misclassified | Originally thought to be a rhabdomyosarcoma cell line but shown to be from an Ewing sarcoma (PubMed=10379870; PubMed=12606131; PubMed=14697648). |
Source Cellosaurus
Papers84
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LSD1 Performs Demethylase-Independent and Context-Specific Roles in Ewing Sarcoma. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Detection of Extracellular Vesicles with Colocalized Surface Markers via a Capture-Release-Capture Strategy for Treatment Monitoring in Ewing Sarcoma. | Adv Healthc Mater | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma. | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LSD1 Performs Demethylase-Independent and Context-Specific Roles in Ewing Sarcoma. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Seclidemstat (SP-2577) Induces Transcriptomic Reprogramming and Cytotoxicity in Multiple Fusion-Positive Sarcomas. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas. | Cancer Immunol Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models. | Cancer Cell | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 84
See all 84 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | A-673 EHD1 KO | CVCL_D6TY | Has a recorded problem | Cell lines |
| Derived from it | A-673 clone Asp114 | CVCL_JM58 | Has a recorded problem | Cell lines |
| Derived from it | A673-SLFN11-KO | CVCL_C6N5 | Has a recorded problem | Cell lines |
| Derived from it | EDITGENE A-673-CopGFP | CVCL_F6CK | Cell lines | |
| Derived from it | EDITGENE A-673-FLUC | CVCL_F5V3 | Cell lines |
Cell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0080
GET https://conductscience.org/api/cell-lines/v1/CVCL_0080/papers?page=2